Cite
HARVARD Citation
Rey, D. et al. (n.d.). Safety and immunogenicity of double-dose versus standard-dose hepatitis B revaccination in non-responding adults with HIV-1 (ANRS HB04 B-BOOST): a multicentre, open-label, randomised controlled trial. Lancet infectious diseases. 15 (11), pp. 1283-1291. [Online].